Sun Pharma Shares
- All
- News
- Videos
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Sun Pharma Shares Tank Over 4% After Q4 Earnings
Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Sun Pharma Profit Rises 13% In September Quarter; Shares Gain Over 2.5%
Sun Pharma's India sales jumped 26 per cent to Rs 3,187 crore while its sales in the US came in at $361 million, up 8 per cent annually.
-
Sensex, Nifty Hit Record Highs Again; IT, FMCG, Pharma Stocks Outperform
Infosys, Tech Mahindra, Asian Paints, TCS, Hindustan Unilever, Sun Pharma and Kotak Mahindra Bank were among the top movers in the Sensex.
-
Sun Pharma Returns To Profit In Q1, Stock Climbs 10% To New 52-Week High
Sun Pharma's earnings before interest, tax, depreciation and amortisation or operating profit advanced 59 per cent annually to Rs 2,771.8 crore
-
Sensex, Nifty End Flat; Sun Pharma Surges Over 10% On Strong Q1 Earnings
Gains in Sun Pharma, Tech Mahindra and HDFC were offset with losses in Reliance Industries, Bajaj Finance and State Bank of India.
-
Sun Pharma Slides Over 4% Post March Quarter Results
Sun Pharma posted a net profit to Rs 894 crore in the fourth quarter ended March 2021, which is a rise of 124 per cent compared to the same quarter last year
-
Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain
Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.
-
Sensex, Nifty Set To Open Marginally Lower; ITC, Sun Pharma In Focus
ITC, the country's largest cigarette maker will be in focus after it reported that its annual net profit declined 12 per cent to Rs 3,663 crore
-
Market Live Updates: Sensex, Nifty Gain For Third Straight Session Led By IT Shares
Tata Consultancy Services, Wipro, Tata Steel, Sun Pharma and JSW Steel, closing between 3.17 per cent and 7.55 per cent higher, were the top Nifty gainers.
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
-
Sun Pharma Says Halol Unit Issues Not Likely To Impact Business, Shares Edge Higher
Sun Pharma said it continues to manufactureand distribute existing products for the US market.
-
Sun Pharma Q2 Profit At Rs 1,064 Crore, Shares Jump Over 3%
On the BSE, the Sun Pharma stock jumped as much as 3.15 per cent to Rs 441.00 apiece after the earnings announcement.
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Sun Pharma Shares Tank Over 4% After Q4 Earnings
Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Sun Pharma Profit Rises 13% In September Quarter; Shares Gain Over 2.5%
Sun Pharma's India sales jumped 26 per cent to Rs 3,187 crore while its sales in the US came in at $361 million, up 8 per cent annually.
-
Sensex, Nifty Hit Record Highs Again; IT, FMCG, Pharma Stocks Outperform
Infosys, Tech Mahindra, Asian Paints, TCS, Hindustan Unilever, Sun Pharma and Kotak Mahindra Bank were among the top movers in the Sensex.
-
Sun Pharma Returns To Profit In Q1, Stock Climbs 10% To New 52-Week High
Sun Pharma's earnings before interest, tax, depreciation and amortisation or operating profit advanced 59 per cent annually to Rs 2,771.8 crore
-
Sensex, Nifty End Flat; Sun Pharma Surges Over 10% On Strong Q1 Earnings
Gains in Sun Pharma, Tech Mahindra and HDFC were offset with losses in Reliance Industries, Bajaj Finance and State Bank of India.
-
Sun Pharma Slides Over 4% Post March Quarter Results
Sun Pharma posted a net profit to Rs 894 crore in the fourth quarter ended March 2021, which is a rise of 124 per cent compared to the same quarter last year
-
Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain
Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.
-
Sensex, Nifty Set To Open Marginally Lower; ITC, Sun Pharma In Focus
ITC, the country's largest cigarette maker will be in focus after it reported that its annual net profit declined 12 per cent to Rs 3,663 crore
-
Market Live Updates: Sensex, Nifty Gain For Third Straight Session Led By IT Shares
Tata Consultancy Services, Wipro, Tata Steel, Sun Pharma and JSW Steel, closing between 3.17 per cent and 7.55 per cent higher, were the top Nifty gainers.
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
-
Sun Pharma Says Halol Unit Issues Not Likely To Impact Business, Shares Edge Higher
Sun Pharma said it continues to manufactureand distribute existing products for the US market.
-
Sun Pharma Q2 Profit At Rs 1,064 Crore, Shares Jump Over 3%
On the BSE, the Sun Pharma stock jumped as much as 3.15 per cent to Rs 441.00 apiece after the earnings announcement.
